MedNews

  • Drug Industry News
  • FDA News & Alerts
  • Health & Medical News
You are here: Home / FDA News & Alerts / Prescribing Information Change: Rocephin (ceftriaxone sodium) for Injection

Prescribing Information Change: Rocephin (ceftriaxone sodium) for Injection

July 6, 2007 By MedNews Leave a Comment

Prescribing Information revised to provide new information regarding the potential risk associated with concomitant use of Rocephin with calcium or calcium containing solutions or products.

Filed Under: FDA News & Alerts Tagged With: calcium, ceftriaxone sodium, Rocephin



Leave a Reply

Your email address will not be published. Required fields are marked *

Search



Tag Cloud

alcohol allergies alzheimers antibiotics breast cancer cancer Centers for Disease Control (CDC) children cholesterol dementia depression Diabetes diet drug abuse exercise fda flu food genetics geriatrics h1n1 heart heart attack heart disease high blood pressure HIV/AIDS hormone therapy hypertension lungs menopause NIH obesity pain pediatrics pregnancy prostate cancer seniors sleep smoking statistics stroke sun teens USA women's health

Recent Comments

  • Mia Fritz on Health Benefits of Dark Chocolate
  • Shilpa on Why Too Much Iron Can Be Dangerous
  • Racheal on Teen Pregnancy May Be Reduced by Sex Education in Schools, Says Study
  • Don on Prilosec, Nexium and Prevacid Tied to Higher Risk of Pneumonia
  • Meso on Brain Changes in Elderly Can Affect Mobility and Balance
  • About Us
  • Contact

Copyright © 2025 Mednews ยท Log in